Jafron Biomedical Co

Jafron Biomedical Co Tangible Book Value per Share

The Tangible Book Value per Share of Jafron Biomedical Co (300529.SZ) as of Oct 15, 2026 is 4.44 CNY. In the previous year, Tangible Book Value per Share was 4.13 CNY — a change of 7.29% (higher).

Tangible Book Value per Share

4.44CNY

YoY

7.29%

Last updated:

Tangible Book Value per Share of Jafron Biomedical Co is 2025 4.44 CNY. Tangible Book Value per Share of Jafron Biomedical Co was 2024 4.13 CNY. It decreases by 7.29% higher compared to the previous year.

The Jafron Biomedical Co Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
2.06 CNY
Jan 1, 2019
2.62 CNY
Jan 1, 2020
3.42 CNY
Jan 1, 2021
4.11 CNY
Jan 1, 2022
4.40 CNY
Jan 1, 2023
3.89 CNY
Jan 1, 2024
4.13 CNY
Jan 1, 2025
4.44 CNY
The Jafron Biomedical Co Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
4.44CNY+7.29%
4.13CNY+6.40%
3.89CNY-11.67%
4.40CNY+6.93%
4.11CNY+20.23%
3.42CNY+30.36%
2.62CNY+27.52%
2.06CNY+19.76%
1.72CNY+15.74%
1.48CNY+114.98%
0.69CNY+25.85%
0.55CNY+8.08%
0.51CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jafron Biomedical Co Stock analysis

What does Jafron Biomedical Co do? Jafron Biomedical Co Ltd is a China-based health care company headquartered in Zhuhai. The company focuses on the research, development, production, and sale of hemoperfusion products. It went public on August 2, 2016, with its stock listed under ticker 300529.SZ and ISIN CNE100002995. Jafron employs 3,003 full-time staff and operates within the health care sector. Its products include disposable hemoperfusion devices, hemoperfusion machines, disposable bilirubin adsorbers, the DX-10 blood purification machine, suture needles, and resin bandages. These products are used in treating conditions such as uremia, poisoning, severe liver diseases, autoimmune diseases, and multisystem organ failure. Jafron's products are distributed across more than 3,000 hospitals in all 31 provinces of China. The company's website is https://www.jafron.com/. Jafron Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jafron Biomedical Co stock

Tangible Book Value per Share of Jafron Biomedical Co is 4.44 CNY in 2025.

Tangible Book Value per Share of Jafron Biomedical Co changed from 4.13 CNY to 4.44 CNY, representing a 7.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Jafron Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Jafron Biomedical Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Jafron Biomedical Co